Pfizer CFO Amit Agarwal resigns, effective October 8, 2026

Cfo ResignedManagement Changes View source PDF Explain this filing

PFIZER · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.3%Reaction day

₹4710.00

prior close

₹4700.00

announcement price

After-mkt

timing

Nifty Smallcap 250market-0.5%+0.8% vs market

Pharmaceuticals peers, median of 165sector-0.8%+1.1% vs sector

On the reaction day the stock moved 0.8 pts more than Nifty Smallcap 250 and 1.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.0

15m

-0.4

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.3-0.5+0.8-0.8+1.1

Next day

+1.1+0.9+0.2+0.2+0.8

+1.9+0.1+1.8-0.7+2.6

+2.4+0.5+1.9-0.3+2.7

+4.1+1.9+2.1+0.3+3.8

+3.0+2.1+0.9+0.7+2.3

+4.1+3.0+1.1+0.3+3.8

15d

+2.4+2.9-0.5+1.0+1.5

-0.2+3.8-3.9+1.6-1.7

-15.6+0.2-15.8+2.4-18.0

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pfizer's Executive Director - Finance and Chief Financial Officer, Mr. Amit Agarwal (DIN: 10465938), has resigned effective close of business on October 8, 2026. He is leaving to pursue an opportunity outside Pfizer. He will also step down as a Board Director and as a member of the CSR Committee, Risk Management Committee, and Board Administrative and Share Transfer Committee from the same date.

Likely market impact

CFO transition may cause short-term uncertainty. Investors should watch for replacement appointment and any strategic shifts at Pfizer.